GET $50 OFF—SIGN UP VIA OUR SITE POP-UP
Our technology may be focused on the entire existing scientific and clinical literature on the microbiome, but our sights are set on the future. Jona Research is focused on the future by driving new science and understandings of the microbiome that push beyond today’s literature.
Fully realizing the microbiome in human medicine will create whole new diagnostics, change patient pathways, make therapies more effective, allow us to develop drugs faster and even produce entirely new classes of therapies.
Although medicine is often aimed at fixing problems. knowledge of the microbiome can also allow us to drive human performance to the next level, creating opportunities in athletics and human longevity. Longer term, we believe that the microbiome can have an even broader impact beyond human health to change how we source foods, agriculture, veterinary care and even cosmetics.
Fully realizing the microbiome in human medicine will create whole new diagnostics, change patient pathways, make therapies more effective, allow us to develop drugs faster and even produce entirely new classes of therapies.
Although medicine is often aimed at fixing problems. knowledge of the microbiome can also allow us to drive human performance to the next level, creating opportunities in athletics and human longevity. Longer term, we believe that the microbiome can have an even broader impact beyond human health to change how we source foods, agriculture, veterinary care and even cosmetics.
HEALTHCARE
+ DIAGNOSIS
DRUG DEVELOPMENT
+ PHARMACEUTICALS
LONGEVITY
+ ANTI-AGING
FOOD + BEVERAGE
ATHLETICS
+ PERFORMANCE
BEAUTY + COSMETICS
We work with biopharma companies running clinical trials in multiple ways
Participant Sourcing
We can help you with faster enrollment and maximize effect size by using the Jona platform to identify patients for enrollment, and improve screening and stratification for likely responders by leveraging the patient microbiome.
Patient engagement
We can also help with patient engagement and increasing return rates on stool samples by offering enrolled patients access to Jona to better understand their own microbiome.
Decoding Data
During the trial, we can help you understand patient progression, response efficacy and identify new biomarkers by providing a comprehensive assessment of exploratory endpoints using the microbiome.
Jona is the only company who has developed a Large Language Model that has ingested the entirety of the clinical and scientific literature to interpret and understand the microbiome.
As a result, we can help you take full advantage of the microbiome in clinical trials and the development of your therapeutic programs, even if the therapies are not seemingly microbiome related. Our team has extensive and unique experience working with the biopharma industry and bringing artificial intelligence to the clinical market.
Chariot
Votre carte est actuellement vide.
